Lung infection and immunology Flashcards

1
Q

What constitutes the upper respiratory tract?

A

Everything above and including the larynx – so, the pharynx, nasal cavity, sinuses, mouth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three categories of defence for the respiratory system? Examples. (x4, x4, x3)

A

MECHANICAL DEFENCES: upper respiratory tract acts as a filter e.g. nasal hairs, muco-ciliary clearance, coughing, epithelium acts as a physical barrier. LOCAL DEFENCES: antimicrobial secretions, ANTIPROTEASES (prevents damage from proteases which come from an immune response) and alveolar macrophages. BALT (look at next flashcard). SYSTEMIC DEFENCES: polymorphonuclear granulocytes, complement and antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the lymphoid tissue of the lungs and what does it do?

A

BALT (Bronchus Associated Lymphoid Tissue): part of the mucosa associated lymphoid tissue (MALT) loosely organised clusters of lymphoid tissue beneath the epithelium of the bronchi in the lungs that samples antigens inhaled through the nose and is the site of priming of adaptive immune responses to airborne pathogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is muco-ciliary clearance?

A

See respiratory cell biology. Cilia in the airways beat metachronally to waft mucous containing microbes towards the throat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the motion that cilia beat?

A

If it went forwards then backwards along the same path, then it would catch mucus on the ay back and push mucus the wrong way. So, each cilium has a very coordinated beat. There is a downward stroke and when it gets to vertical, it engages with the mucus and pushes it forward; when it gets to the bottom of the forward stroke, the cilium is withdrawn in a curved fashion (image on the right). Cilia also have little claws on their ends – more in respiratory anatomy – that engage with the mucus. They beat metachronally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How may muco-ciliary clearance be compromised – two causes (two examples for one category; three for the other)?

A

ACQUIRED: pathogenic damage: viral infections can lead to destruction of the cilia and tight between epithelial cells, before opportunistic bacteria invade. Cilia must regrow, taking weeks, and can regrow as useless COMPOUND CILIA – compound cilia are shown in the image. Can also be caused by cigarette smoke.

CONGENITAL: MICROTUBULE ABNORMALITIES (abnormal microtubules can lead to non-functional cilia and dextrocardia because microtubules guide cells during embryogenesis (so if dextrocardia, check cilia function)); DYNEIN ARM DEFECTS (lack of outer dynein arm, and there’s only inner arms instead (look at photo) prevents the cilia from mucociliary clearance (look at photo)); PRIMARY CILIARY DYSKINESIA (lack of nasal NO is a cause/biomarker associated with malfunctioning cilia – disorder when mutant cilia do not have dynein arms so cilia are static).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What can ciliary defects lead to?

A

Ineffective muco-ciliary clearance and BRONCHIECTASIS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does congenital mean?

A

A disease or abnormality present from birth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathophysiology of pneumococcal pneumonia and how does it lead to symptoms?

A

An ACUTE lung infection. It is a type of pneumonia commonly caused by the bacteria STREPTOCOCCUS PNEUMONIAE, which leads to coughing, sputum, fever and dyspnoea because the alveoli become filled with pus, meaning the lung becomes SOLID. There is also PERIPHERAL INFLAMMATION which leads to STABBING PLEURITIC CHEST PAIN – airways are not scarred and some effort can be made to clear infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is pus?

A

Debris of the host trying to fight the infection. This is what fills the alveoli in pneumonia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pathophysiology of bronchiectasis? What are the symptoms of bronchiectasis? (x4) Significance of the mucus accumulation?

A

A CHRONIC lung infection where AIRWAYS BECOME SCARRED, widened and INFLAMED with thick mucous that the patient will struggle to clear. Pockets of mucous form and harbour bacteria that can multiply, but are not cleared leading to chronic infection and inflammation mediated by neutrophils – inability to clear mucous because of damage means airways cannot easily clear infections.

Sputum production, recurrent respiratory infections, breathlessness, fatigue.

Physiotherapy is important. If the lungs are emptied of the mucous that potentially contains pathogens, you remove the stimulus for neutrophils to move in and hence REDUCE INFLAMMATION.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the difference between an acute and chronic respiratory infection?

A

ACUTE: neutrophils secrete proteases to destroy microbes during inflammation and infection, and normally this is balanced by anti-proteases in the airways.

CHRONIC: the number of neutrophils is VERY LARGE, so the anti-proteases are overwhelmed leading to increased free proteases causing damage to the airway epithelia (which in turn impairs the lung defences, making it easier to be infected, and leading to further inflammation, further damage and MORE infection - creating a vicious cycle – LOOK AT PHOTO).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

***Where do the proteases come from? Relate this to chronic infection!

A

When a phagocyte (neutrophil) gets into the airway, it phagocytoses the bacterium and produces PROTEASES that kill the pathogen – some of these proteases are spilled into the surrounding secretions. Antiproteases are sat in the airways to neutralise proteases and stop it from DAMAGING THE BODY. In chronic infection and inflammation, there are too many neutrophils, so the antiproteases are overwhelmed, so you get FREE PROTEASES which sit in sputum and cause damage!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens histologically in chronic inflammation and the constant traffic of neutrophils?

A

Protease chews away at epithelial surface, causing damage and allowing infections to colonise the damaged areas. A CHOCOLATE BROWN SUBSTANCE is produced which is the ELASTIN of the bronchial walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the general cause of pneumonia, in the context of the microbes naturally found in the lungs?

A

Lung is not a sterile organ – it contains many of the microorganisms that cause pneumonia, naturally. The advent of a bacterial pneumonia is likely to be in the background of a common viral infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two types of pneumonia? What pathogens are associated with each type?

A

COMMUNITY ACQUIRED PNEUMONIA: Not just Streptococcus pneumoniae (for pneumococcal pneumonia), but viruses like rhinovirus, influenza A/B are associated with the disease. SO, there’s a cooperative process between the virus AND the bacterium, that leads to the disease.

HOSPITAL ACQUIRED PNEUMONIA: Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the epidemiology of pneumonia?

A

Increases exponentially with age. Death increases with an even greater increase with age too i.e. older people are more susceptible to death with pneumonia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the risk factors of pneumonia? (x8)

A
  1. Less than 2 and more than 65 years old.
  2. Smoking.
  3. Alcohol consumption.
  4. Poverty.
  5. Contact with small children.
  6. Overcrowding.
  7. Medications e.g. corticosteroids, immunosuppressants and proton pump inhibitor usage.
  8. Medical history: COPD, Asthma…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the symptoms of pneumonia? (x4)

A
  1. Acute lower respiratory symptoms: coughing, sputum, dyspnoea, hypoxia…
  2. Pleuritic chest pain.
  3. New X-ray changes i.e. X-ray changes regularly with infection.
  4. At least one systemic feature: fevers, headache, shivers, aches and pains, increased temperature.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What causes the stabbing pleuritic chest pain in pneumonia?

A

The pain is actually called ‘stabbing pleuritic chest pain’, so remember it! There are pain fibres on the surface of the lungs, so when the lungs become solid and the inflammation gets out to the periphery, they become stimulated and there’s pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does the lower respiratory tract refer to?

A

Refers to respiratory tree – describes the branching structure of the airways supplying air to the lungs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is hypersensitivity?

A

Exaggerated response to a foreign substance irrespective of the mechanism – can be immunological or non-immunological.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is an allergy?

A

An exaggerated IMMUNOLOGICAL response to a foreign substance (allergen) which is inhaled, swallowed, injected or placed on the skin or eyes. It is a TYPE OF HYPERSENSITIVITY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the pathophysiology of allergic disease?

A

In susceptible individuals, non-infectious material in the environment such as polled and house dust mite can trigger a type 2 immune response, giving rise to allergic disease. Type 2 immune response is supposed to be delivered to protect against helminths and ectoparasites (ecto- means outer).

25
Q

What are the three types of non-immunological hypersensitivity? (an example for each)

A

Can be due to INTOLERANCE (food), ENZYME DEFICIENCY (lactase DH deficiency) and PHARMACOLOGICALLY based (aspirin hypersensitivity).

26
Q

What is intolerance?

A

The presence of symptoms following environmental exposure or food ingestion where an immunological mechanism is not established.

27
Q

What are the two types of immunological hypersensitivity? (x2)

A

IgE-mediated (atopic disease) and those that are not IgE-mediated (e.g. Farmer’s lung).

28
Q

What is atopy?

A

A hereditary predisposition to produce specific IgE antibodies to common aeroallergens.

29
Q

What examples are there of atopy? (x2)

A

Allergic rhinitis and asthma.

30
Q

What are the three types of allergic airway disease?

A

UPPER AIRWAYS ALLERGIC AIRWAY DISEASE: allergic rhinitis (informally ‘hay fever’). LOWER AIRWAYS: asthma. ALVEOLAR SPACES: extrinsic allergic alveolitis.

31
Q

What is the mechanism of allergic rhinitis?

A

KNOWN AS SEASONAL ALLERGIES.

HAY FEVER.

It is an UPPER AIRWAYS allergic disease – refers to NASAL AIRWAYS!

  1. Allergens pass over epithelium in the airways and are captured by dendritic cells.
  2. Dendritic cells migrate to lymph nodes and stimulate T helper cells to differentiate into T follicular helper cells (using interleukin-4) and TH2 cells (using interleukin-9) that activate B cells and mast cells respectively.
  3. T follicular helper cells stimulate B cells to become plasma cells that secrete allergen specific IgE antibodies that bind to FcE receptors on mast cells – specialised cells found in CONNECTIVE TISSUE and AIRWAYS. (NOTE how this is an atopic response.)
  4. When the allergen CROSS-LINKS WITH IgE ANTIBODIES (basically means ‘to bind’) on mast cells, degranulation occurs leading to histamine release = inflammation and more.
32
Q

How is allergic rhinitis treated? (x2)

A

Specific allergen immunotherapy aka hypo-sensitisation: antihistamines for relief of symptoms. AND topical corticosteroids for suppression of allergic inflammation.

33
Q

What is the epidemiology of allergic rhinitis?

A

Affects up to 25% of the population

34
Q

What is the mechanism of extrinsic allergic alveolitis?

A
  1. Extrinsic allergic alveolitis concerns very SMALL allergenic particles which penetrate distal airways (bronchioles) and enter alveoli, then interstitium.
  2. Particles are captured by antibodies in the interstitium to form antigen-antibody complexes.
  3. Complement and immunological cascades are triggered, and lymphocytes are recruited.
  4. Immunological response is triggered = INFLAMMATION of the alveoli.
35
Q

What is another name for extrinsic allergic alveolitis?

A

Hypersensitivity pneumonitis.

36
Q

What is the pathophysiology of asthma?

A

There is inflammation of the large (bronchi) and small airways (bronchioles) as a result of an allergen – driving a Type 2 Immunological response. As a result, there is contraction of the smooth muscle cell, secretion of mucous by goblet cells, infiltration of T cells and eosinophils. Results in an irritable airway in which airflow is obstructed. Occurs when exposed to a variety of non-specific irritants (bronchial hyper-responsiveness).

37
Q

How is asthma treated? (x2)

A

DEPENDS because asthma has wide phenotype: Mild asthma with occasional wheezing = controlled by the occasional use of inhaled bronchodilators. Severe intractable (hard to control) disease = requires treatment using systemic corticosteroids.

38
Q

What is the epidemiology of asthma?

A

10% of the population, though the condition is very heterogenous and phenotypes vary. Incidence is plateauing though.

39
Q

How do the phenotypes of asthma vary? (x2 points of focus)

A

Asthma is very heterogenous and phenotypes vary by CONTROL AND SEVERITY (e.g. some are intermittent and mild, others are chronic, severe and uncontrolled by treatment), and phenotypes vary by ENDOTYPE (An ‘endotype’ is proposed to be a subtype of a condition defined by a distinct pathophysiological mechanism e.g. eosinophilic, neutrophilic or exercise-induced asthma).

40
Q

What is the epidemiology of allergic airways disease?

A

Incidence in developed countries is rising. No obvious increase in developing countries. 2004, UK: 39% of children and 30% of adults had been diagnosed with one or more of asthma, eczema (allergic, but not allergic airways disease) and hay fever.

41
Q

What is a possible cause of the rising trends in allergic diseases? (x2 theories)

A

BIOME DEPLETION: In Western countries, the developing immune system is deprived of the microbial antigens that stimulate regulatory T cells and Th1 cells because the environment is clean and because of childhood vaccinations and the widespread use of antibiotics for minor illnesses in early life. Our gut and lung flora have lost some of these antigens so that it no longer provides an anti-allergic milieu.

EXPOSURE CHANGES: the co-factors required for the development of diseases like an asthmatic attack may include respiratory virus infections and exposure to increased allergens, tobacco smoke, and air pollutants. These exposures may have increased in developed countries where there is an observed increase.

42
Q

What are the principles of treatment of allergic airways diseases? (x3 principles)

A

Avoidance of allergen, antiallergic medication AND specific allergen immunotherapy.

43
Q

What examples are there of antiallergic medication? (x2)

A

Antihistamines e.g. H1-blocker (aka Histamine H1-receptor antagonist).

Steroids e.g. intra-nasal steroids.

44
Q

What is the action of Histamine H1-receptor antagonists?

A

Less sedative (other antihistamines are notorious for causing sleepiness) and more pharmacologically selective than older antihistamines. Some H1-blockers such as cetirizine also inhibit allergen-induced tissue eosinophilia – it’s unsure whether this effect is H1-independent though.

45
Q

What is subcutaneous injection (SCIT) in the context of allergic airways disease? What type of allergic treatment is this? Ways of administration?

A

Type of treatment = SPECIFIC IMMUNOTHERAPY. Involves administering increasing concentrations of allergenic extracts over long periods of time. METHODS OF ADMINISTRATION: Sublingual (orally) and subcutaneous (needle).

46
Q

What are the advantages and disadvantages of specific immunotherapy? (x2 and x3)

A

ADVANTAGES: effective and produces long-lasting immunity. DISADVANTAGES: occasional severe allergic reaction (risk of anaphylaxis, particularly in the induction phase), time consuming and standardisation problems.

47
Q

What is the result of specific immunotherapy? (x4 points) Three mechanisms that make this happen?

A

PRINCIPLE: (i) inhibit the release of mediators from mast cells and basophils, (ii) prevent infiltration of allergic LESIONS by inflammatory cells and (iii) reduce number of tissue mast cells. (iv) It also aims to reduce the numbers of IgE and bring about non-responsiveness.

  1. B cells become Bregs (regulatory cells) that inhibit B cells or become plasma cells that produce IgG/A antibodies: IgG “blocking antibodies” compete with IgE for allergen – may prevent aggregation of FcRI IgE complexes on mast cells, and interferes with antigen-trapping by IgE bound to antigen-presenting cells. Reducing hypersensitivity response.
  2. Specific immunotherapy induces a shift from Th2 to Th1 cells, decreased production of IL-4 and IL-5 and increased IFN-y and IL-12 production. Over years, the IgE concentrations become reduced.
  3. Induces IL-10 secreting Treg cells which inhibit TfH cells, stopping the production of IgE antibodies, and therefore exerting anti-allergy and non-responsive effects.  
48
Q

How should a patient history be taken? (x6 stages)

A
  1. PRESENTING COMPLAINT: brief and patient’s own words.
  2. HISTORY PRESENTING COMPLAINT: tailored questions to rule in/out diagnoses, previous similar episodes?
  3. PAST MEDICAL HISTORY: Medical and surgical.
  4. MEDICATIONS AND ALLERGIES: dose and duration.
  5. FAMILY HISTORY.
  6. SOCIAL HISTORY: occupation, smoking, alcohol, living situation, social support.
49
Q

What is cystic fibrosis?

A

Multi-system disease caused by mutation in CTFR genes (autosomal recessive). Pathophysiology occurs as a cycle: INFECTION, INFLAMMATION, LUNG DAMAGE and COLONISATION of the damaged areas by pathogens… Has a median survival of 40 years.

50
Q

How is cystic fibrosis diagnosed?

A

Diagnosed in childhood – presence of 2 CTFR mutations and positive sweat test (more than 60mmol/L – measures amount of chloride in the is excreted in sweat).

51
Q

How is cystic fibrosis managed?

A

Antibiotics, airway clearance, hypertonic saline, macrolides (antibacterial), oxygen, lung transplant. OTHERS: high calorie high protein diet, enteral tube feeding (tube through the nose for feeding) and fat-soluble vitamins A/E/K/D.

52
Q

What are transplant INDICATIONS and REQUIREMENTS – the difference?

A

INDICATIONS: things that would make someone need a transplant. REQUIREMENTS: things that the patient must meet for the transplant e.g. not obese…

53
Q

What are the lung transplant INDICATIONS? (x7)

A
  1. FEV1 is less than 30% of predicted. 2. PaO2 is less than 7.3kPa. 3. PaCO2 is more than 6.7kPa. 4. Increasingly frequent pulmonary exacerbations. 5. Recurrent pneumothoraxes. 6. Recurrent haemoptysis. 7. Life expectancy is less than 3 years.
54
Q

What are the lung transplant REQUIREMENTS? (x7).

A
  1. No renal, heart or liver disease. 2. No osteoporosis. 3. BMI between 17 and 30. 4. No untreatable psychiatric conditions. 5. No history of cancer in the last 5 years. 6. Reliable social support. 7. Good adherence to medications and appointments
55
Q

What conditions may warrant a lung transplant? (x5)

A

COPD, interstitial lung disease, cystic fibrosis, bronchiectasis, idiopathic pulmonary arterial hypertension.

56
Q

What are the two risks post-lung-transplant?

A

INFECTION: immunosuppression allows viral, bacterial and fungal infection.

REJECTION: can be acute or chronic.

57
Q

REJECTION: can be acute or chronic. What is the difference between acute and chronic rejection?

A

ACUTE: cell-mediated mechanism – CD4, CD8 (T-lymphocytes) and macrophages.

CHRONIC: mixed humoral and cellular mechanisms – T-lymphocytes AND antibodies from B cells.

58
Q

What is needed post-lung-transplantation in patients?

A
  1. Immunosuppression and other medications.
  2. Lifestyle adaptation – diet, travel and appointments.
  3. Frequent appointments and admissions for antibiotics, steroids and bronchoscopy.